Score Overview
Explore the 2021 public Archive ranking β
Where Innoviva Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row β but not in 2021.
- INVA
2010: 39.1% Β· 2021: 3.7% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 21.23 | β |
1 Year2025-09-26 | $ 18.86 | 12.57% |
5 Years2021-09-28 | $ 17.20 | 23.43% |
10 Years2016-09-28 | $ 11.21 | 89.38% |
20 Years2006-09-28 | $ 20.00 | 6.13% |
All Time2004-10-05 | $ 13.55 | 56.71% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2004-10-05 |
|---|---|---|---|---|---|---|
| Price | $ 21.23 | $ 18.86 | $ 17.20 | $ 11.21 | $ 20.00 | $ 13.55 |
| Return | β | 12.57% | 23.43% | 89.38% | 6.13% | 56.71% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 443M | $ 357M | $ 570M |
| 2025 | $ 425M | $ 271M | $ 550M |
| 2024 | $ 358M | $ 23M | $ 412M |
| 2023 | $ 310M | $ 179M | $ 193M |
| 2022 | $ 331M | $ 213M | $ 291M |
| 2021 | $ 391M | $ 265M | $ 201M |
| 2020 | $ 336M | $ 224M | $ 246M |
| 2019 | $ 261M | $ 157M | $ 350M |
| 2018 | $ 261M | $ 395M | $ 114M |
| 2017 | $ 217M | $ 134M | $ 129M |
| 2016 | $ 133M | $ 59M | $ 150M |
| 2015 | $ 53M | -$ 18M | $ 187M |
| 2014 | $ 8M | -$ 168M | $ 240M |
| 2013 | $ 4M | -$ 170M | $ 465M |
| 2012 | $ 5M | -$ 18M | $ 248M |
| 2011 | $ 24M | -$ 115M | $ 240M |
| 2010 | $ 24M | -$ 83M | $ 309M |
| 2009 | $ 24M | -$ 85M | $ 155M |
| 2008 | $ 23M | -$ 93M | $ 200M |
| 2007 | $ 22M | -$ 159M | $ 126M |
| 2006 | $ 19M | -$ 166M | $ 201M |
| 2005 | $ 12M | -$ 143M | $ 161M |
| IPO2004 | $ 8M | -$ 102M | $ 257M |

Innoviva Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 53M to $ 425M and net income went from -$ 18M to $ 271M. Revenue increased in 8 of those 10 years; net income in 6.
Between 2005 and 2025, revenue grew from $ 12M to $ 425M and net income went from -$ 143M to $ 271M. Revenue increased in 15 of those 20 years; net income in 14.
Innoviva Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Continue INVAβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Neogen CorporationNEOGΒ· revenue grew in 90% of years
Omnicell IncOMCLΒ· revenue grew in 80% of years
Fresenius Medical Care CorporationFMSΒ· revenue grew in 80% of years
Ligand Pharmaceuticals IncorporatedLGNDΒ· revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMYΒ· revenue grew in 65% of years